Abstract
Purpose
Thyroid-stimulating hormone (TSH) has a pulsatile and circadian rhythm in healthy individuals. We aimed to evaluate the diurnal changes of free thyroid hormones and serum TSH levels in patients with end-stage renal failure (ESRF) whose thyroidal functions are at normal ranges.
Methods
Thirty hemodialysis patients with chronic renal failure and without a known thyroidal disease who are over 18 and 35 healthy individuals were included. The serum TSH, free T3, and free T4 levels were examined among the patient and control group which were taken at 8:00 a.m., 4:00 p.m., and 0:00 a.m.
Results
Twenty-two (73.3%) patients were male, and the mean age of the patient group was 64 (sd = 14.45 years). Seventeen (48.6%) of the control group were female, and the mean age was 31.9 (sd = 6.4 years). Serum free T3 levels, measured at three different time points (8:00 a.m., 4:00 p.m., and 0:00 a.m.), were significantly lower in the patient group than in the control group and serum free T4 levels were measured at three different time points (8:00 am, 4:00 p.m., and 0:00 a.m.) were significantly higher in the patient group than in the control group. Serum TSH levels were higher in the patient group than in the control group at 08:00, and were lower at 24:00 (p < 0.001). The nocturnal increase of serum TSH level under 0.525 suggested diurnal rhythm disruption with 83% sensitivity and 87% specificity.
Conclusion
The nocturnal serum TSH increase is not seen in ESRF patients who did not have a thyroid disease. We think that not observing a nocturnal TSH increase could be an early indication of the sick euthyroid syndrome.
Similar content being viewed by others
References
T.K. Chen, D.H. Knicely, M.E. Grams, Chronic kidney disease diagnosis and management: a review. JAMA 322(13), 1294–1304 (2019)
C.M. Rhee, G.A. Brent, C.P. Kovesdy et al. Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. Nephrol. Dial. Transplant. 30(5), 724–737 (2015)
M.R. Wiederkehr, J. Kalogiros, R. Krapf, Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol. Dial. Transplant. 19(5), 1190–1197 (2004)
B. Pan, X. Du, H. Zhang, X. Hua, X. Wan, C. Cao, Relationships of chronic kidney disease and thyroid dysfunction in non-dialysis patients: a pilot study. Kidney Blood Press. Res. 44(2), 170–178 (2019)
G. Xu, W. Yan, J. Li, An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases. Clin. Exp. Nephrol. 18(6), 837–843 (2014)
I.J.C. An, assessment of daily production and significance of thyroidal secretion of 3,3,3’,5’-triiodothyronine (reverse T3) in man. J. Clin. Investig. 58, 32–40 (1976)
E.M. Kaptein, E.I. Feinstein, J.T. Nicoloff, S.G. Massry, Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. J. Clin. Endocrinol. Metab. 57(1), 181–189 (1983)
D.S. Silverberg, R.A. Ulan, D.M. Fawcett, J.B. Dossetor, M. Grace, K. Bettcher, Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can. Med Assoc. J. 109(4), 282–286 (1973)
E.M. Kaptein, Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr. Rev. 17(1), 45–63 (1996)
M. Mohamedali, S. Reddy Maddika, A. Vyas, V. Iyer, P. Cheriyath, Thyroid disorders and chronic kidney disease. Int. J. Nephrol. 2014, 520281 (2014)
L. Duntas, C.F. Wolf, F.S. Keck, J. Rosenthal, Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Clin. Nephrol. 38(4), 214–218 (1992)
G. Ramirez, W. O’Neill Jr, W. Jubiz, H.A. Bloomer, Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann. Intern. Med. 84(6), 672–676 (1976)
E. van der Spoel, F. Roelfsema, D. van Heemst, Within-person variation in serum thyrotropin concentrations: main sources, potential underlying biological mechanisms, and clinical implications. Front. Endocrinol. 12, 619568 (2021)
H. AN, in Regulation of thyrotropin secretion. ed. by L.E. Braverman. Werner and Ingbar’s The Thyroid A Fundamental and Clinical Text. 9th ed. (Philadelphia Lippincott Williams and Wilkins, 2005), pp. 197–213
A.S. Levey, J. Coresh, T. Greene et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145(4), 247–254 (2006)
H. Xu, N. Brusselaers, B. Lindholm, C. Zoccali, J.J. Carrero, Thyroid function test derangements and mortality in dialysis patients: a systematic review and meta-analysis. Am. J. Kidney Dis. 68(6), 923–32. (2016)
V.S. Lim, Thyroid function in patients with chronic renal failure. Am. J. Kidney Dis. 38), S80–S84 (2001)
J.A. Romijn, W.M. Wiersinga, Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J. Clin. Endocrinol. Metab. 70(1), 35–42 (1990)
M.H. Samuels, P.A. McDaniel, Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research center study. J. Clin. Endocrinol. Metab. 82(11), 3700–3704 (1997)
M.H. Samuels, K. Lillehei, B.K. Kleinschmidt-Demasters, J. Stears, E.C. Ridgway, Patterns of pulsatile pituitary glycoprotein secretion in central hypothyroidism and hypogonadism. J. Clin. Endocrinol. Metab. 70(2), 391–395 (1990)
P. Kok, F. Roelfsema, M. Frolich, A.E. Meinders, H. Pijl, Spontaneous diurnal thyrotropin secretion is enhanced in proportion to circulating leptin in obese premenopausal women. J. Clin. Endocrinol. Metab. 90(11), 6185–6191 (2005)
P.J. Caron, L.K. Nieman, S.R. Rose, B.C. Nisula, Deficient nocturnal surge of thyrotropin in central hypothyroidism. J. Clin. Endocrinol. Metab. 62(5), 960–964 (1986)
L. Bartalena, E. Martino, L. Petrini et al. The nocturnal serum thyrotropin surge is abolished in patients with adrenocorticotropin (ACTH)-dependent or ACTH-independent Cushing’s syndrome. J. Clin. Endocrinol. Metab. 72(6), 1195–1199 (1991)
R. Atalay, R. Ersoy, A.B. Demirezer et al. Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver. Endocrine 48(3), 942–948 (2015)
T. Wheatley, P.M. Clark, J.D. Clark, R. Holder, P.R. Raggatt, D.B. Evans, Abnormalities of thyrotrophin (TSH) evening rise and pulsatile release in haemodialysis patients: evidence for hypothalamic-pituitary changes in chronic renal failure. Clin. Endocrinol. 31(1), 39–50 (1989)
S. Sakurai, Y. Hara, S. Miura et al. Thyroid functions before and after maintenance hemodialysis in patients with chronic renal failure. Endocrinol. Jpn. 35(6), 865–876 (1988)
C. Zoccali, F. Mallamaci, G. Tripepi, S. Cutrupi, P. Pizzini, Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 70(3), 523–528 (2006)
G. Bellastella, M.I. Maiorino, L. Scappaticcio et al. TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability. J. Endocrinol. Investig. 41(4), 389–93. (2018)
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
Before running the research, we received ethics committee approval from Ankara Atatürk Education and Research Hospital Ethics Committee (No:15). Study code were 25.06.2012-25. All people in the patient and control group filled informed consent form.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Soylu, H., Ersoy, R., Keske, P.B. et al. The diurnal change of thyroid-stimulating hormone and the effect of this change on thyroid functions in patients with chronic kidney disease. Endocrine 82, 580–585 (2023). https://doi.org/10.1007/s12020-023-03446-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03446-z